Andrew Burke

Dr Andrew Burke currently works with the UQ Centre for Clinical Research, The University of Queensland and is dual specialist in both infectious diseases and thoracic medicine at The Prince Charles Hospital, Brisbane. He has diverse clinical experience in low income countries and regional Australia and holds a Diploma in Tropical Medicine and Hygiene (Liverpool) and a Masters in Public Health from the University of Queensland.

Andrew is a principal investigator on a number of industry lead trials for pulmonary NTM infection. He is an associate investigator on the FORMAT study assessing clinical outcomes in pulmonary Mycobacterium abscessus infection and with Professor Jason Roberts of UQCCR is leading the pharmacokinetic sub-studies in this multi-national trial.

Andrew is on the Australian Therapeutic Guidelines writing groups for both antibiotics and respiratory disease. He is current chair of the steering committee of the Australasian Clinical Tuberculosis network (ACTnet) and is on the Queensland Tuberculosis Expert Advisory Group. He is currently undertaking a PhD in the pharmacokinetics of mycobacterial drugs in people with tuberculosis and cystic fibrosis. As part of his PhD he is exploring the role of therapeutic drug montioring in complex mycobacterial infections and sees great potential for Australian and Asia-Pacific researchers to contribute to mycobacterial research through involvement in PK studies.